Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners

Journal of Bone and Mineral Metabolism

Volumn 27, Issue 1, 2009, Pages 24-35

  Takahashi, Masahiro ^a   Mizoguchi, Toshihide ^a   Uehara, Shunsuke ^a   Nakamichi, Yuko ^a   Yang, Shuhua ^a   Naramoto, Hiroko ^a   Yamashita, Teruhito ^a   Kobayashi, Yasuhiro ^a   Yamaoka, Minoru ^a   Furusawa, Kiyofumi ^a   Udagawa, Nobuyuki ^a   Uematsu, Takashi ^a   Takahashi, Naoyuki ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

Author keywords

Bone resorption; Docetaxel; Microtubule; Osteoblast; Osteoclast

Indexed keywords

CALCITRIOL; DOCETAXEL; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PACLITAXEL; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL FUNCTION; CELL LEVEL; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG INHIBITION; MACROPHAGE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOOTH PERIAPICAL DISEASE; TRANSCYTOSIS;

ACTINS; ANIMALS; ANTINEOPLASTIC AGENTS; BONE AND BONES; BONE MARROW CELLS; BONE RESORPTION; CALCITRIOL; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DINOPROSTONE; GLUTAMIC ACID; HUMANS; MACROPHAGES; MALE; MICE; OSTEOBLASTS; OSTEOCLASTS; PACLITAXEL; RANK LIGAND; TAXOIDS;

EID: 58149182695     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-008-0013-y     Document Type: Article

References (44)

1. A Lipton 2006 Future treatment of bone metastases Clin Cancer Res 12 6305s 6308s
2. GR Mundy 2002 Metastasis to bone: causes, consequences and therapeutic opportunities Nat Rev Cancer 2 584 593
3. GA Clines TA Guise 2005 Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone Endocr Relat Cancer 12 549 583
4. GD Roodman 2004 Mechanisms of bone metastasis N Engl J Med 350 1655 1664
5. T Hiraga A Myoui ME Choi H Yoshikawa T Yoneda 2006 Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-β enhances bone metastases in breast cancer Cancer Res 66 2067 2073
6. J Crown M O'Leary 2000 The taxanes: an update Lancet 355 1176 1178
7. MP Piechocki F Lonardo JF Ensley T Nguyen H Kim GH Yoo 2002 Anticancer activity of docetaxel in murine salivary gland carcinoma Clin Cancer Res 8 870 877
8. DL Morse H Gray CM Payne RJ Gillies 2005 Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells Mol Cancer Ther 4 1495 1504
9. M Marty F Cognetti D Maraninchi R Snyder L Mauriac M Tubiana-Hulin S Chan D Grimes A Anton A Lluch J Kennedy K O'Byrne P Conte M Green C Ward K Mayne JM Extra 2005 Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group J Clin Oncol 23 4265 4274
10. H Joensuu PL Kellokumpu-Lehtinen P Bono T Alanko V Kataja 2006 Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer N Engl J Med 354 809 820
11. LA Amos J Lowe 1999 How Taxol stabilises microtubule structure Chem Biol 6 R65 R69
12. GA Orr P Verdier-Pinard H McDaid SB Horwitz 2003 Mechanisms of Taxol resistance related to microtubules Oncogene 22 7280 7295
13. K Subbaramaiah JC Hart L Norton AJ Dannenberg 2000 Microtubule- interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways J Biol Chem 275 14838 14845
14. 2-terminal kinase (JNK/SAPK) J Biol Chem 273 28253 28360
15. TH Wang HS Wang YK Soong 2000 Paclitaxel-induced cell death: where the cell cycle and apoptosis come together Cancer (Phila) 88 2619 2628
16. K Subbaramaiah TP Marmo DA Dixon AJ Dannenberg 2003 Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR J Biol Chem 278 37637 37647
17. K Kawasaki S Akashi R Shimazu T Yoshida K Miyake M Nishijima 2000 Mouse toll-like receptor 4-MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol J Biol Chem 275 2251 2254
18. CA Byrd-Leifer EF Block K Takeda S Akira A Ding 2001 The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol Eur J Immunol 31 2448 2457
19. M Yamamoto K Takeda S Akira 2004 TIR domain-containing adaptors define the specificity of TLR signaling Mol Immunol 40 861 868
20. K Kawasaki K Gomi Y Kawai M Shiozaki M Nishijima 2003 Identification of mouse MD-2 residues important for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-MD-2 antibodies, and for conferring LPS and taxol responsiveness on mouse TLR4 by alanine-scanning mutagenesis J Immunol 170 413 420
21. TJ Chambers 2000 Regulation of the differentiation and function of osteoclasts J Pathol 192 4 13
22. T Suda N Takahashi N Udagawa E Jimi MT Gillespie TJ Martin 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr Rev 20 345 357
23. WJ Boyle WS Simonet DL Lacey 2003 Osteoclast differentiation and activation Nature (Lond) 423 337 342
24. HK Väänänen H Zhao M Mulari JM Halleen 2000 The cell biology of osteoclast function J Cell Sci 113 377 381
25. P Jurdic F Saltel A Chabadel O Destaing 2006 Podosome and sealing zone: specificity of the osteoclast model Eur J Cell Biol 85 195 202
26. S Okumura T Mizoguchi N Sato M Yamaki Y Kobayashi H Yamauchi H Ozawa N Udagawa N Takahashi 2006 Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networks Bone (NY) 39 684 693
27. SA Nesbitt MA Horton 1997 Trafficking of matrix collagens through bone-resorbing osteoclasts Science 276 266 269
28. J Salo P Lehenkari M Mulari K Metsikko HK Väänänen 1997 Removal of osteoclast bone resorption products by transcytosis Science 276 270 273
29. R Morimoto S Uehara S Yatsushiro N Juge Z Hua S Senoh N Echigo M Hayashi T Mizoguchi T Ninomiya N Udagawa H Omote A Yamamoto RH Edwards Y Moriyama 2006 Secretion of l-glutamate from osteoclasts through transcytosis EMBO J 25 4175 4186
30. Y Moriyama A Yamamoto 2004 Glutamatergic chemical transmission: look! Here, there, and anywhere J Biochem (Tokyo) 135 155 163
31. TJ Hall H Jeker M Schaueblin 1995 Taxol inhibits osteoclastic bone resorption Calcif Tissue Int 57 463 465
32. K Inoue T Karashima S Fukata A Nomura C Kawada A Kurabayashi M Furihata Y Ohtsuki T Shuin 2005 Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma Clin Cancer Res 11 6669 6677
33. X Li N Udagawa M Takami N Sato Y Kobayashi N Takahashi 2003 p38 MAPK is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis or dendritic cell differentiation of bone marrow macrophages Endocrinology 144 4999 5005
34. 3 in osteoclast differentiation and function Methods Enzymol 282 223 235
35. N Sato N Takahashi K Suda M Nakamura M Yamaki T Ninomiya Y Kobayashi H Takada K Shibata M Yamamoto K Takeda S Akira T Noguchi N Udagawa 2004 MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyllipopeptide, and IL-1α J Exp Med 200 601 611
36. S Tanaka N Takahashi N Udagawa T Tamura T Akatsu ER Stanley T Kurokawa T Suda 1993 Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors J Clin Invest 91 257 263
37. E Jimi S Akiyama T Tsurukai N Okahashi K Kobayashi N Udagawa T Nishihara N Takahashi T Suda 1999 Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function J Immunol 163 434 442
38. O Destaing F Saltel JC Geminard P Jurdic F Bard 2003 Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein Mol Biol Cell 14 407 416
39. H Tsuboi N Udagawa J Hashimoto H Yoshikawa N Takahashi T Ochi 2005 Nurse-like cells from patients with rheumatoid arthritis support the survival of osteoclast precursors via macrophage colony-stimulating factor production Arthritis Rheum 52 3819 3828
40. I Brown K Shalli SL McDonald SE Moir AW Hutcheon SD Heys AC Schofield 2004 Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells Breast Cancer Res 6 R601 R607
41. Y Li O Kucuk M Hussain J Abrams ML Cher FH Sarkar 2006 Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer Cancer Res 66 4816 4825
42. AF Stewart 2002 Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton J Bone Miner Res 17 758 762
43. MK Lee AM Vincent P Jyoti C John GA Christopher G Jorge GK Mark TH Robert P Barbara T Leslie S Christine SR Jeffrey V Ennapadam 2005 Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced non-small cell lung carcinoma Cancer (Phila) 10 2149 2155
44. KK Tamila AO Gregory Y Donn N Anterpreet C Tamara N Gerard S Richie D Robert A Miguel C Villalona 2005 Phase II evaluation of docetaxel-modulated capecitabine in previously treated patients with non-small cell lung cancer Clin Cancer Res 11 1870 1876